Lefeng Wang

1.7k total citations
76 papers, 876 citations indexed

About

Lefeng Wang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lefeng Wang has authored 76 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 34 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lefeng Wang's work include Coronary Interventions and Diagnostics (26 papers), Acute Myocardial Infarction Research (22 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Lefeng Wang is often cited by papers focused on Coronary Interventions and Diagnostics (26 papers), Acute Myocardial Infarction Research (22 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Lefeng Wang collaborates with scholars based in China, United States and Canada. Lefeng Wang's co-authors include Jiuchang Zhong, Xinming Liu, Xinchun Yang, Sanjay Mehta, Li Xu, Dapeng Zhang, Lirong Liang, Zhiyong Zhang, Huanan Wang and Ravi Taneja and has published in prestigious journals such as SHILAP Revista de lepidopterología, Circulation Research and The FASEB Journal.

In The Last Decade

Lefeng Wang

71 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lefeng Wang China 19 343 244 239 135 116 76 876
Lang Li China 20 313 0.9× 272 1.1× 188 0.8× 117 0.9× 49 0.4× 63 860
Michel Kindo France 18 402 1.2× 234 1.0× 353 1.5× 126 0.9× 84 0.7× 69 1.0k
Zubair Shah United States 18 571 1.7× 242 1.0× 397 1.7× 68 0.5× 74 0.6× 84 1.2k
Nikolaos Papoutsidakis Greece 15 552 1.6× 367 1.5× 309 1.3× 96 0.7× 38 0.3× 38 1.2k
Andrea D’Amato Italy 18 531 1.5× 179 0.7× 265 1.1× 79 0.6× 23 0.2× 62 1.0k
Carlo Lavalle Italy 19 887 2.6× 165 0.7× 218 0.9× 67 0.5× 34 0.3× 112 1.3k
Damian Craig United States 14 294 0.9× 327 1.3× 318 1.3× 34 0.3× 69 0.6× 23 906
Tsun-Jui Liu Taiwan 16 324 0.9× 247 1.0× 220 0.9× 72 0.5× 19 0.2× 50 800
Charalampos Kossyvakis Greece 17 722 2.1× 314 1.3× 168 0.7× 148 1.1× 114 1.0× 55 1.2k
Siamak Davani France 15 186 0.5× 275 1.1× 276 1.2× 72 0.5× 40 0.3× 44 960

Countries citing papers authored by Lefeng Wang

Since Specialization
Citations

This map shows the geographic impact of Lefeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lefeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lefeng Wang more than expected).

Fields of papers citing papers by Lefeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lefeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lefeng Wang. The network helps show where Lefeng Wang may publish in the future.

Co-authorship network of co-authors of Lefeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lefeng Wang. A scholar is included among the top collaborators of Lefeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lefeng Wang. Lefeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Fu, Yuan, Xinming Liu, Hong-Jiang Wang, et al.. (2023). Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction. European journal of medical research. 28(1). 334–334. 2 indexed citations
5.
Liu, Xinming, Hong-Jiang Wang, Zhiyong Zhang, et al.. (2023). Comparisons of different new-generation transcatheter aortic valve implantation devices for patients with severe aortic stenosis: a systematic review and network meta-analysis. International Journal of Surgery. 109(8). 2414–2426. 2 indexed citations
6.
Li, Jiangyuan, Liang Lu, Xu Li, et al.. (2023). A Novel Reperfusion Strategy for Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: A Prospective Case Series. Journal of Clinical Medicine. 12(2). 433–433. 1 indexed citations
7.
Fu, Yuan, Kun Zuo, Yuanfeng Gao, et al.. (2022). Distal Transradial Access: a Safe and Feasible Approach for Coronary Catheterization in Cases of Total Radial Artery Occlusion. Journal of Cardiovascular Translational Research. 15(5). 1203–1211. 6 indexed citations
8.
Wang, Lefeng, et al.. (2022). Feasibility and Safety of Drug-Coated Balloon-Only Angioplasty for De Novo Ostial Lesions of the Left Anterior Descending Artery: Two-Center Retrospective Study. Frontiers in Cardiovascular Medicine. 9. 874394–874394. 6 indexed citations
9.
Li, Heng, Lefeng Wang, Xiayu Li, et al.. (2022). Serum IgE Levels Are Associated With the Prognosis of Minimal Change Disease. Frontiers in Immunology. 13. 840857–840857. 1 indexed citations
10.
Liu, Xinming, Zhenzhou Zhang, Jiuchang Zhong, et al.. (2021). Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury through the PI3K/Akt/eNOS pathway by sponging miRNA-133a-3p to target IGF1R expression. European Journal of Pharmacology. 916. 174719–174719. 18 indexed citations
12.
Zhang, Dapeng, Li Xu, Lefeng Wang, Hong-Jiang Wang, & Feng Jiang. (2020). Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis. Cardiovascular Diabetology. 19(1). 10–10. 33 indexed citations
13.
Li, Chuang, et al.. (2020). Gender differences and survival after an out-of-hospital cardiac arrest: a systematic review and meta-analysis. Internal and Emergency Medicine. 16(3). 765–775. 28 indexed citations
14.
Xu, Bo, Yuejin Yang, Yaling Han, et al.. (2018). Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial. EuroIntervention. 14(5). e554–e561. 25 indexed citations
15.
Zhang, Zhiyong, Yingxue Li, Xinchun Yang, et al.. (2018). Susceptibility of multiple polymorphisms in ADIPOQ , ADIPOR1 and ADIPOR2 genes to myocardial infarction in Han Chinese. Gene. 658. 10–17. 9 indexed citations
16.
Wang, Lefeng, et al.. (2018). Differential Mechanisms of Septic Human Pulmonary Microvascular Endothelial Cell Barrier Dysfunction Depending on the Presence of Neutrophils. Frontiers in Immunology. 9. 1743–1743. 14 indexed citations
17.
Li, Kuibao, et al.. (2017). Interaction Between Vitamin D and Lipoprotein (a) on the Presence and Extent of Coronary Heart Disease. Heart Lung and Circulation. 26(10). 1079–1084. 3 indexed citations
18.
19.
Sun, Hao, Lefeng Wang, Kuibao Li, et al.. (2015). Long-term outcomes following very late stent thrombosis of drug-eluting stent. Journal of Cardiology. 66(6). 496–501. 7 indexed citations
20.
Li, Xiaotao, Hao Sun, Dapeng Zhang, et al.. (2014). Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions. Coronary Artery Disease. 25(5). 405–411. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026